ECHA and industry must invest and engage more in SVHC substitution
The European market lacks investment in SVHC substitution, hindering progress. The Lowell centre recommends building infrastructures, increasing engagement, and enhancing technical capacity to support the analysis of alternatives. Authorities face challenges in identifying, evaluating, and adopting SVHC substitution. ECHA can play a key role in supporting these initiatives. For more information on SVHCs, visit our website.